
Alicia Morgans, MD, discusses ARACOG findings on cognitive outcomes with darolutamide vs enzalutamide and the influence of genetic dementia risk.
“More research needs to be done, but I think this is something that gets the conversation started,” says Tony Chen, MD.
In this video, Tony Chen, MD, discusses the study, “





